week 6 semaglutide once a in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial Semaglutide week 2, shot 3!

Ferulic acid attenuates diabetes-induced cognitive impairment in rats via regulation of PTP1B and insulin signaling pathway

Brazil Market Trends The market in Latin America is led by Brazil, where penetration of private insurance is high, and where there are large volumes of public procurement

If HbA1c targets are not met after an adequate trial, treatment should be reviewed and intensified in line with agreed individual targets and NICE guidance

PMCID: PMC9861237

Regulatory Compliance: All of our medicines and healthcare products are manufactured by FSSAI, GMP, iso 9001, and WHO-GMP

Lumen: Metabolic Insights Lumen isn't GLP-1 specific, but it provides valuable metabolic feedback